nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP3A7—Ifosfamide—germ cell cancer	0.202	0.241	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.202	0.241	CbGbCtD
Ethosuximide—CYP3A5—Ifosfamide—germ cell cancer	0.152	0.18	CbGbCtD
Ethosuximide—CYP2E1—Etoposide—germ cell cancer	0.0933	0.111	CbGbCtD
Ethosuximide—CYP3A5—Etoposide—germ cell cancer	0.0725	0.0862	CbGbCtD
Ethosuximide—CYP3A4—Ifosfamide—germ cell cancer	0.0591	0.0704	CbGbCtD
Ethosuximide—CYP3A4—Vinblastine—germ cell cancer	0.0314	0.0373	CbGbCtD
Ethosuximide—CYP3A4—Etoposide—germ cell cancer	0.0283	0.0336	CbGbCtD
Ethosuximide—Microscopic hematuria—Ifosfamide—germ cell cancer	0.0161	0.101	CcSEcCtD
Ethosuximide—Swollen tongue—Etoposide—germ cell cancer	0.00584	0.0366	CcSEcCtD
Ethosuximide—Paranoia—Ifosfamide—germ cell cancer	0.00319	0.02	CcSEcCtD
Ethosuximide—Aggression—Bleomycin—germ cell cancer	0.00289	0.0181	CcSEcCtD
Ethosuximide—Aplastic anaemia—Dactinomycin—germ cell cancer	0.00223	0.014	CcSEcCtD
Ethosuximide—Hiccups—Cisplatin—germ cell cancer	0.00187	0.0117	CcSEcCtD
Ethosuximide—Pancytopenia—Vinblastine—germ cell cancer	0.00179	0.0112	CcSEcCtD
Ethosuximide—Lethargy—Dactinomycin—germ cell cancer	0.00176	0.011	CcSEcCtD
Ethosuximide—Agranulocytosis—Vinblastine—germ cell cancer	0.00157	0.00985	CcSEcCtD
Ethosuximide—Psychotic disorder—Ifosfamide—germ cell cancer	0.00154	0.00966	CcSEcCtD
Ethosuximide—Pancytopenia—Bleomycin—germ cell cancer	0.00152	0.0095	CcSEcCtD
Ethosuximide—Weight decreased—Bleomycin—germ cell cancer	0.00144	0.00905	CcSEcCtD
Ethosuximide—Breast disorder—Ifosfamide—germ cell cancer	0.00143	0.00894	CcSEcCtD
Ethosuximide—Pancytopenia—Dactinomycin—germ cell cancer	0.00141	0.00886	CcSEcCtD
Ethosuximide—Haematuria—Bleomycin—germ cell cancer	0.00136	0.0085	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.00132	0.00825	CcSEcCtD
Ethosuximide—Irritability—Cisplatin—germ cell cancer	0.0013	0.00814	CcSEcCtD
Ethosuximide—Pancytopenia—Ifosfamide—germ cell cancer	0.0013	0.00812	CcSEcCtD
Ethosuximide—Agranulocytosis—Dactinomycin—germ cell cancer	0.00124	0.00776	CcSEcCtD
Ethosuximide—Breast disorder—Cisplatin—germ cell cancer	0.00123	0.00771	CcSEcCtD
Ethosuximide—Cramp muscle—Cisplatin—germ cell cancer	0.00123	0.00768	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.00121	0.00756	CcSEcCtD
Ethosuximide—Leukopenia—Vinblastine—germ cell cancer	0.00118	0.00739	CcSEcCtD
Ethosuximide—Haematuria—Ifosfamide—germ cell cancer	0.00116	0.00727	CcSEcCtD
Ethosuximide—Agranulocytosis—Ifosfamide—germ cell cancer	0.00113	0.00711	CcSEcCtD
Ethosuximide—Abdominal discomfort—Cisplatin—germ cell cancer	0.00113	0.00707	CcSEcCtD
Ethosuximide—Erythema multiforme—Dactinomycin—germ cell cancer	0.00113	0.00706	CcSEcCtD
Ethosuximide—Cramp muscle—Etoposide—germ cell cancer	0.00112	0.00703	CcSEcCtD
Ethosuximide—Pancytopenia—Cisplatin—germ cell cancer	0.00112	0.007	CcSEcCtD
Ethosuximide—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00108	0.00676	CcSEcCtD
Ethosuximide—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00107	0.00672	CcSEcCtD
Ethosuximide—Urethral disorder—Ifosfamide—germ cell cancer	0.00107	0.00671	CcSEcCtD
Ethosuximide—Erythema multiforme—Ifosfamide—germ cell cancer	0.00103	0.00647	CcSEcCtD
Ethosuximide—Anorexia—Vinblastine—germ cell cancer	0.00102	0.00642	CcSEcCtD
Ethosuximide—Pancytopenia—Etoposide—germ cell cancer	0.00102	0.00641	CcSEcCtD
Ethosuximide—Eye disorder—Ifosfamide—germ cell cancer	0.00102	0.00639	CcSEcCtD
Ethosuximide—Leukopenia—Bleomycin—germ cell cancer	0.000995	0.00624	CcSEcCtD
Ethosuximide—Immune system disorder—Ifosfamide—germ cell cancer	0.000986	0.00618	CcSEcCtD
Ethosuximide—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000984	0.00617	CcSEcCtD
Ethosuximide—Aplastic anaemia—Methotrexate—germ cell cancer	0.000966	0.00605	CcSEcCtD
Ethosuximide—Mental disorder—Ifosfamide—germ cell cancer	0.000956	0.00599	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000952	0.00597	CcSEcCtD
Ethosuximide—Malnutrition—Ifosfamide—germ cell cancer	0.00095	0.00596	CcSEcCtD
Ethosuximide—Decreased appetite—Vinblastine—germ cell cancer	0.000934	0.00585	CcSEcCtD
Ethosuximide—Urinary tract disorder—Cisplatin—germ cell cancer	0.000929	0.00583	CcSEcCtD
Ethosuximide—Leukopenia—Dactinomycin—germ cell cancer	0.000928	0.00582	CcSEcCtD
Ethosuximide—Connective tissue disorder—Cisplatin—germ cell cancer	0.000925	0.0058	CcSEcCtD
Ethosuximide—Urethral disorder—Cisplatin—germ cell cancer	0.000923	0.00578	CcSEcCtD
Ethosuximide—Agranulocytosis—Etoposide—germ cell cancer	0.000896	0.00562	CcSEcCtD
Ethosuximide—Eye disorder—Cisplatin—germ cell cancer	0.00088	0.00551	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000879	0.00551	CcSEcCtD
Ethosuximide—Agitation—Ifosfamide—germ cell cancer	0.000873	0.00547	CcSEcCtD
Ethosuximide—Anorexia—Bleomycin—germ cell cancer	0.000865	0.00542	CcSEcCtD
Ethosuximide—Urinary tract disorder—Etoposide—germ cell cancer	0.000851	0.00534	CcSEcCtD
Ethosuximide—Leukopenia—Ifosfamide—germ cell cancer	0.000851	0.00533	CcSEcCtD
Ethosuximide—Immune system disorder—Cisplatin—germ cell cancer	0.00085	0.00533	CcSEcCtD
Ethosuximide—Abdominal pain—Vinblastine—germ cell cancer	0.000849	0.00532	CcSEcCtD
Ethosuximide—Mediastinal disorder—Cisplatin—germ cell cancer	0.000848	0.00532	CcSEcCtD
Ethosuximide—Urethral disorder—Etoposide—germ cell cancer	0.000845	0.0053	CcSEcCtD
Ethosuximide—Malnutrition—Cisplatin—germ cell cancer	0.000819	0.00514	CcSEcCtD
Ethosuximide—Erythema multiforme—Etoposide—germ cell cancer	0.000815	0.00511	CcSEcCtD
Ethosuximide—Anorexia—Dactinomycin—germ cell cancer	0.000807	0.00506	CcSEcCtD
Ethosuximide—Eye disorder—Etoposide—germ cell cancer	0.000806	0.00505	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000803	0.00504	CcSEcCtD
Ethosuximide—Hypersensitivity—Vinblastine—germ cell cancer	0.000792	0.00496	CcSEcCtD
Ethosuximide—Decreased appetite—Bleomycin—germ cell cancer	0.000789	0.00494	CcSEcCtD
Ethosuximide—Muscle spasms—Cisplatin—germ cell cancer	0.000788	0.00494	CcSEcCtD
Ethosuximide—Immune system disorder—Etoposide—germ cell cancer	0.000779	0.00488	CcSEcCtD
Ethosuximide—Mediastinal disorder—Etoposide—germ cell cancer	0.000777	0.00487	CcSEcCtD
Ethosuximide—Asthenia—Vinblastine—germ cell cancer	0.000771	0.00483	CcSEcCtD
Ethosuximide—Lethargy—Methotrexate—germ cell cancer	0.000762	0.00477	CcSEcCtD
Ethosuximide—Nervous system disorder—Ifosfamide—germ cell cancer	0.000761	0.00477	CcSEcCtD
Ethosuximide—Skin disorder—Ifosfamide—germ cell cancer	0.000753	0.00472	CcSEcCtD
Ethosuximide—Anorexia—Ifosfamide—germ cell cancer	0.000739	0.00463	CcSEcCtD
Ethosuximide—Decreased appetite—Dactinomycin—germ cell cancer	0.000736	0.00461	CcSEcCtD
Ethosuximide—Diarrhoea—Vinblastine—germ cell cancer	0.000735	0.00461	CcSEcCtD
Ethosuximide—Leukopenia—Cisplatin—germ cell cancer	0.000733	0.0046	CcSEcCtD
Ethosuximide—Fatigue—Dactinomycin—germ cell cancer	0.00073	0.00457	CcSEcCtD
Ethosuximide—Muscle spasms—Etoposide—germ cell cancer	0.000722	0.00452	CcSEcCtD
Ethosuximide—Urticaria—Bleomycin—germ cell cancer	0.000721	0.00452	CcSEcCtD
Ethosuximide—Irritability—Methotrexate—germ cell cancer	0.000713	0.00447	CcSEcCtD
Ethosuximide—Dizziness—Vinblastine—germ cell cancer	0.000711	0.00445	CcSEcCtD
Ethosuximide—Ataxia—Methotrexate—germ cell cancer	0.000702	0.0044	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000693	0.00434	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000692	0.00434	CcSEcCtD
Ethosuximide—Somnolence—Ifosfamide—germ cell cancer	0.000689	0.00432	CcSEcCtD
Ethosuximide—Vomiting—Vinblastine—germ cell cancer	0.000683	0.00428	CcSEcCtD
Ethosuximide—Breast disorder—Methotrexate—germ cell cancer	0.000675	0.00423	CcSEcCtD
Ethosuximide—Decreased appetite—Ifosfamide—germ cell cancer	0.000674	0.00423	CcSEcCtD
Ethosuximide—Headache—Vinblastine—germ cell cancer	0.000673	0.00422	CcSEcCtD
Ethosuximide—Leukopenia—Etoposide—germ cell cancer	0.000672	0.00421	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00067	0.0042	CcSEcCtD
Ethosuximide—Abdominal pain—Dactinomycin—germ cell cancer	0.000669	0.00419	CcSEcCtD
Ethosuximide—Fatigue—Ifosfamide—germ cell cancer	0.000669	0.00419	CcSEcCtD
Ethosuximide—Hypersensitivity—Bleomycin—germ cell cancer	0.000669	0.00419	CcSEcCtD
Ethosuximide—Nervous system disorder—Cisplatin—germ cell cancer	0.000656	0.00411	CcSEcCtD
Ethosuximide—Asthenia—Bleomycin—germ cell cancer	0.000651	0.00408	CcSEcCtD
Ethosuximide—Skin disorder—Cisplatin—germ cell cancer	0.000649	0.00407	CcSEcCtD
Ethosuximide—Eosinophilia—Methotrexate—germ cell cancer	0.000639	0.004	CcSEcCtD
Ethosuximide—Nausea—Vinblastine—germ cell cancer	0.000638	0.004	CcSEcCtD
Ethosuximide—Anorexia—Cisplatin—germ cell cancer	0.000637	0.00399	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000635	0.00398	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000634	0.00398	CcSEcCtD
Ethosuximide—Hypersensitivity—Dactinomycin—germ cell cancer	0.000624	0.00391	CcSEcCtD
Ethosuximide—Abdominal discomfort—Methotrexate—germ cell cancer	0.000619	0.00388	CcSEcCtD
Ethosuximide—Urticaria—Ifosfamide—germ cell cancer	0.000616	0.00386	CcSEcCtD
Ethosuximide—Abdominal pain—Ifosfamide—germ cell cancer	0.000613	0.00384	CcSEcCtD
Ethosuximide—Pancytopenia—Methotrexate—germ cell cancer	0.000613	0.00384	CcSEcCtD
Ethosuximide—Asthenia—Dactinomycin—germ cell cancer	0.000607	0.00381	CcSEcCtD
Ethosuximide—Skin disorder—Etoposide—germ cell cancer	0.000595	0.00373	CcSEcCtD
Ethosuximide—Anorexia—Etoposide—germ cell cancer	0.000584	0.00366	CcSEcCtD
Ethosuximide—Decreased appetite—Cisplatin—germ cell cancer	0.000581	0.00364	CcSEcCtD
Ethosuximide—Diarrhoea—Dactinomycin—germ cell cancer	0.000579	0.00363	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000577	0.00362	CcSEcCtD
Ethosuximide—Vomiting—Bleomycin—germ cell cancer	0.000577	0.00362	CcSEcCtD
Ethosuximide—Drowsiness—Methotrexate—germ cell cancer	0.000575	0.00361	CcSEcCtD
Ethosuximide—Rash—Bleomycin—germ cell cancer	0.000572	0.00359	CcSEcCtD
Ethosuximide—Dermatitis—Bleomycin—germ cell cancer	0.000572	0.00358	CcSEcCtD
Ethosuximide—Hypersensitivity—Ifosfamide—germ cell cancer	0.000571	0.00358	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.00057	0.00357	CcSEcCtD
Ethosuximide—Asthenia—Ifosfamide—germ cell cancer	0.000556	0.00349	CcSEcCtD
Ethosuximide—Haematuria—Methotrexate—germ cell cancer	0.000549	0.00344	CcSEcCtD
Ethosuximide—Somnolence—Etoposide—germ cell cancer	0.000545	0.00341	CcSEcCtD
Ethosuximide—Nausea—Bleomycin—germ cell cancer	0.000539	0.00338	CcSEcCtD
Ethosuximide—Vomiting—Dactinomycin—germ cell cancer	0.000538	0.00337	CcSEcCtD
Ethosuximide—Agranulocytosis—Methotrexate—germ cell cancer	0.000537	0.00337	CcSEcCtD
Ethosuximide—Rash—Dactinomycin—germ cell cancer	0.000534	0.00334	CcSEcCtD
Ethosuximide—Decreased appetite—Etoposide—germ cell cancer	0.000532	0.00334	CcSEcCtD
Ethosuximide—Diarrhoea—Ifosfamide—germ cell cancer	0.000531	0.00333	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000529	0.00331	CcSEcCtD
Ethosuximide—Fatigue—Etoposide—germ cell cancer	0.000528	0.00331	CcSEcCtD
Ethosuximide—Dizziness—Ifosfamide—germ cell cancer	0.000513	0.00321	CcSEcCtD
Ethosuximide—Urinary tract disorder—Methotrexate—germ cell cancer	0.00051	0.0032	CcSEcCtD
Ethosuximide—Urethral disorder—Methotrexate—germ cell cancer	0.000506	0.00317	CcSEcCtD
Ethosuximide—Nausea—Dactinomycin—germ cell cancer	0.000503	0.00315	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Etoposide—germ cell cancer	0.000501	0.00314	CcSEcCtD
Ethosuximide—Vomiting—Ifosfamide—germ cell cancer	0.000493	0.00309	CcSEcCtD
Ethosuximide—Hypersensitivity—Cisplatin—germ cell cancer	0.000493	0.00309	CcSEcCtD
Ethosuximide—Rash—Ifosfamide—germ cell cancer	0.000489	0.00307	CcSEcCtD
Ethosuximide—Dermatitis—Ifosfamide—germ cell cancer	0.000489	0.00306	CcSEcCtD
Ethosuximide—Erythema multiforme—Methotrexate—germ cell cancer	0.000488	0.00306	CcSEcCtD
Ethosuximide—Urticaria—Etoposide—germ cell cancer	0.000487	0.00305	CcSEcCtD
Ethosuximide—Abdominal pain—Etoposide—germ cell cancer	0.000484	0.00304	CcSEcCtD
Ethosuximide—Eye disorder—Methotrexate—germ cell cancer	0.000483	0.00303	CcSEcCtD
Ethosuximide—Asthenia—Cisplatin—germ cell cancer	0.00048	0.00301	CcSEcCtD
Ethosuximide—Immune system disorder—Methotrexate—germ cell cancer	0.000466	0.00292	CcSEcCtD
Ethosuximide—Mediastinal disorder—Methotrexate—germ cell cancer	0.000465	0.00292	CcSEcCtD
Ethosuximide—Nausea—Ifosfamide—germ cell cancer	0.000461	0.00289	CcSEcCtD
Ethosuximide—Diarrhoea—Cisplatin—germ cell cancer	0.000457	0.00287	CcSEcCtD
Ethosuximide—Mental disorder—Methotrexate—germ cell cancer	0.000452	0.00284	CcSEcCtD
Ethosuximide—Hypersensitivity—Etoposide—germ cell cancer	0.000451	0.00283	CcSEcCtD
Ethosuximide—Malnutrition—Methotrexate—germ cell cancer	0.00045	0.00282	CcSEcCtD
Ethosuximide—Asthenia—Etoposide—germ cell cancer	0.000439	0.00275	CcSEcCtD
Ethosuximide—Vomiting—Cisplatin—germ cell cancer	0.000425	0.00266	CcSEcCtD
Ethosuximide—Rash—Cisplatin—germ cell cancer	0.000422	0.00264	CcSEcCtD
Ethosuximide—Dermatitis—Cisplatin—germ cell cancer	0.000421	0.00264	CcSEcCtD
Ethosuximide—Diarrhoea—Etoposide—germ cell cancer	0.000419	0.00263	CcSEcCtD
Ethosuximide—Dizziness—Etoposide—germ cell cancer	0.000405	0.00254	CcSEcCtD
Ethosuximide—Leukopenia—Methotrexate—germ cell cancer	0.000402	0.00252	CcSEcCtD
Ethosuximide—Nausea—Cisplatin—germ cell cancer	0.000397	0.00249	CcSEcCtD
Ethosuximide—Vomiting—Etoposide—germ cell cancer	0.000389	0.00244	CcSEcCtD
Ethosuximide—Rash—Etoposide—germ cell cancer	0.000386	0.00242	CcSEcCtD
Ethosuximide—Dermatitis—Etoposide—germ cell cancer	0.000386	0.00242	CcSEcCtD
Ethosuximide—Headache—Etoposide—germ cell cancer	0.000384	0.00241	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00038	0.00238	CcSEcCtD
Ethosuximide—Nausea—Etoposide—germ cell cancer	0.000364	0.00228	CcSEcCtD
Ethosuximide—Nervous system disorder—Methotrexate—germ cell cancer	0.00036	0.00226	CcSEcCtD
Ethosuximide—Skin disorder—Methotrexate—germ cell cancer	0.000356	0.00223	CcSEcCtD
Ethosuximide—Anorexia—Methotrexate—germ cell cancer	0.00035	0.00219	CcSEcCtD
Ethosuximide—Somnolence—Methotrexate—germ cell cancer	0.000326	0.00204	CcSEcCtD
Ethosuximide—Decreased appetite—Methotrexate—germ cell cancer	0.000319	0.002	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000317	0.00199	CcSEcCtD
Ethosuximide—Fatigue—Methotrexate—germ cell cancer	0.000316	0.00198	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.0003	0.00188	CcSEcCtD
Ethosuximide—Urticaria—Methotrexate—germ cell cancer	0.000291	0.00183	CcSEcCtD
Ethosuximide—Abdominal pain—Methotrexate—germ cell cancer	0.00029	0.00182	CcSEcCtD
Ethosuximide—Hypersensitivity—Methotrexate—germ cell cancer	0.00027	0.00169	CcSEcCtD
Ethosuximide—Asthenia—Methotrexate—germ cell cancer	0.000263	0.00165	CcSEcCtD
Ethosuximide—Diarrhoea—Methotrexate—germ cell cancer	0.000251	0.00157	CcSEcCtD
Ethosuximide—Dizziness—Methotrexate—germ cell cancer	0.000243	0.00152	CcSEcCtD
Ethosuximide—Vomiting—Methotrexate—germ cell cancer	0.000233	0.00146	CcSEcCtD
Ethosuximide—Rash—Methotrexate—germ cell cancer	0.000231	0.00145	CcSEcCtD
Ethosuximide—Dermatitis—Methotrexate—germ cell cancer	0.000231	0.00145	CcSEcCtD
Ethosuximide—Headache—Methotrexate—germ cell cancer	0.00023	0.00144	CcSEcCtD
Ethosuximide—Nausea—Methotrexate—germ cell cancer	0.000218	0.00137	CcSEcCtD
